Archive: NKT Cell Properties for Neuroblastoma Immunotherapy
910 views · Published 15 October 2015 · 32:38 · Indexed 14 November 2026
Channel: UW Video · 2015 · Education
Dr. Leonid S. Metelitsa of Texas Children's Cancer Center and Baylor College of Medicine speaks on the role of natural killer T cells (NKT) in immunotherapy of neuroblastoma at the 4th International Conference on Immunotherapy in Pediatric Oncology (CIPO2015), hosted by Seattle Children’s Research Institute. Dr. Metelitsa discusses how NKT cells can localize to the tumor site and mediate anti-tumor activity via killing or reprogramming of tumor-associated macrophages. He also describes how NKT cells can be grafted with an additional anti-tumor specificity via expression of a chimeric antigen receptor to enable dual targeting of tumor cells and tumor-supportive machrophages. Leonid S. Metelitsa, MD, PhD, Professor of Pediatrics & Immunology, Texas Children's Cancer Center/Baylor College of Medicine 09/26/2015 http://www.seattlechildrens.org/research/ http://www.seattlechildrens.org/research/childhood-cancer/CIPO-2015/ https://uw.edu/video The University of Washington is committed to ensuring digital accessibility in our services, programs, and activities. If you encounter accessibility barriers using videos found on this channel, please contact UW Video at uwvideo [at] uw [dot] edu.
More from this channel
-
54:45
Archive: Usable Privacy and Security: Protecting People from Online Phishing Scams
-
58:27
Archive: Technology for Long-Term Care: Scaling Elder Care to the Next Billion
-
53:34
Archive: Closing the Innovation Gap
-
52:34
Archive: Hardness Amplification by Repetition
-
54:57
Archive: Network Coded Wireless Architecture
-
56:48
Archive: Computer Science Research for Global Development
-
58:16
Archive: Thinking Historically about Thinking Historically: Identity Politics to Ethical Action
-
27:18
Archive: Eastside Specialty Center: Coordination of Care